Literature DB >> 12115572

Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden.

Kari Hemminki1, Charlotta Granström, Kamila Czene.   

Abstract

Population attributable factions (PAFs) show the proportion of the disease that could be prevented if the cause could be removed. The PAF for familial breast cancer has not been precisely determined. We used the nationwide Swedish Family-Cancer Database on 10.2 million individuals and 190,000 mothers' and 26,000 daughters' breast cancers to calculate familial standardized incidence ratios (SIRs), proportion of cases with a family history and familial PAFs for all invasive and in situ and morphology-specific breast cancers in daughters who were 0-66 years old. The data were calculated by mother only, sister only or both as probands. More than 5,500 familial breast cancers were recorded. The familial SIRs for all invasive breast cancer were 1.79 by breast cancer in the mother only, 2.03 by breast cancer in a sister only and 2.82 by breast cancer in both a mother and sister. The familial PAFs were 3.61, 3.01 and 0.43%, respectively, giving a total PAF of 7.05%. Age-specific risks were shown for the mother and sister history of breast cancer. The PAF values decreased by age when the daughter had a mother history of breast cancer but not when she had a sister history. PAFs did not depend on the morphologic type of breast cancer. The data show that the familial PAF of breast cancer among a 0-66-year-old population of daughters was 7% and independent of the morphologic type. If contribution from the paternal side was allowed for, the PAF would be 11%. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12115572     DOI: 10.1002/ijc.10467

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Intraductal papilloma of the breast in association with preoncogenic gene of breast cancer.

Authors:  Tuenchit Khammapirad; Jenjeera Prueksadee; Concepcion Diaz-Arrastia; Shaleen K Botting; Morton Leonard; Louisea Bonoan-Deomampo; Mahmoud A Eltorky
Journal:  Asian Pac J Trop Biomed       Date:  2011-04

2.  Family history of malignancies and risk of breast cancer: prospective data from the Shanghai women's health study.

Authors:  Briseis A Kilfoy; Yawei Zhang; Xiao-Ou Shu; Yu-Tang Gao; Bu-Tian Ji; Gong Yang; Hong Lan Li; Nathaniel Rothman; Wong-Ho Chow; Wei Zheng
Journal:  Cancer Causes Control       Date:  2008-06-25       Impact factor: 2.506

3.  Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.

Authors:  Daniel J Park; Kayoko Tao; Florence Le Calvez-Kelm; Tu Nguyen-Dumont; Nivonirina Robinot; Fleur Hammet; Fabrice Odefrey; Helen Tsimiklis; Zhi L Teo; Louise B Thingholm; Erin L Young; Catherine Voegele; Andrew Lonie; Bernard J Pope; Terrell C Roane; Russell Bell; Hao Hu; Chad D Huff; Jonathan Ellis; Jun Li; Igor V Makunin; Esther M John; Irene L Andrulis; Mary B Terry; Mary Daly; Saundra S Buys; Carrie Snyder; Henry T Lynch; Peter Devilee; Graham G Giles; John L Hopper; Bing-Jian Feng; Fabienne Lesueur; Sean V Tavtigian; Melissa C Southey; David E Goldgar
Journal:  Cancer Discov       Date:  2014-05-02       Impact factor: 39.397

4.  Age of onset in familial cancer.

Authors:  A Brandt; J Lorenzo Bermejo; J Sundquist; K Hemminki
Journal:  Ann Oncol       Date:  2008-07-24       Impact factor: 32.976

5.  Evidence for familial clustering in breast cancer age of onset.

Authors:  Ann Von Holle; Katie M O'Brien; Dale P Sandler; Clarice R Weinberg
Journal:  Int J Epidemiol       Date:  2021-03-03       Impact factor: 7.196

Review 6.  Image-based screening for men at high risk for breast cancer: Benefits and drawbacks.

Authors:  Ryan W Woods; Lonie R Salkowski; Mai Elezaby; Elizabeth S Burnside; Roberta M Strigel; Amy M Fowler
Journal:  Clin Imaging       Date:  2019-11-28       Impact factor: 1.605

7.  The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.

Authors:  Lutécia H Mateus Pereira; Marbin A Pineda; William H Rowe; Libia R Fonseca; Mark H Greene; Kenneth Offit; Nathan A Ellis; Jinghui Zhang; Andrew Collins; Jeffery P Struewing
Journal:  BMC Genet       Date:  2007-10-04       Impact factor: 2.797

8.  Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast.

Authors:  Ethel-Michele de Villiers; Robert E Sandstrom; Harald zur Hausen; Charles E Buck
Journal:  Breast Cancer Res       Date:  2004-10-22       Impact factor: 6.466

9.  Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects.

Authors:  Zhi-Jun Dai; Hua-Feng Kang; Xi-Jing Wang; Yong-Ping Shao; Shuai Lin; Yang Zhao; Hong-Tao Ren; Wei-Li Min; Meng Wang; Xiao-Xu Liu
Journal:  Cancer Cell Int       Date:  2014-09-05       Impact factor: 5.722

10.  A constant risk for familial breast cancer? A population-based family study.

Authors:  Kamila Czene; Marie Reilly; Per Hall; Mikael Hartman
Journal:  Breast Cancer Res       Date:  2009-05-20       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.